Therefore, BTN2/3 subfamily expression could possibly promote the development of pan-glioma by enhancing PD1 expression interacting with PDL1 and inhibiting CD4 and CD8 T-cell differentiation by upregulating CTLA4. This evidence concerns the gene CD8A and central nervous system cancer.